ClariVest Asset Management’s Dr. Reddy's Laboratories RDY Stock Holding History

ClariVest Asset Management’s Portfolio RDY Stock Details RDY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-50,000	Closed	-$734K	–	921
2024 Q1	$734K	Sell	50,000 -55	-0.1%	-$803	0.08%	317
2023 Q4	$697K	Sell	50,055 -1,500	-3%	-$20.1K	0.04%	323
2023 Q3	$690K	Buy	51,555 +51,500	+93,636%	+$697K	0.04%	309
2023 Q2	$1K	Hold	55	–	–	﹤0.01%	631
2023 Q1	$1K	Buy	+55	New	+$594	﹤0.01%	687
2021 Q1	–	Sell	-221,000	Closed	-$3.15M	–	797
2020 Q4	$3.15M	Sell	221,000 -5,500	-2%	-$74.1K	0.11%	165
2020 Q3	$3.15M	Sell	226,500 -100,000	-31%	-$1.19M	0.1%	157
2020 Q2	$3.46M	Sell	326,500 -55,000	-14%	-$559K	0.09%	160
2020 Q1	$3.08M	Sell	381,500 -60,000	-14%	-$500K	0.09%	148
2019 Q4	$3.58M	Sell	441,500 -68,000	-13%	-$537K	0.08%	179
2019 Q3	$3.86M	Hold	509,500	–	–	0.09%	188
2019 Q2	$3.82M	Sell	509,500 -18,000	-3%	-$142K	0.09%	185
2019 Q1	$4.27M	Sell	527,500 -219,000	-29%	-$1.66M	0.09%	203
2018 Q4	$5.63M	Buy	746,500 +270,500	+57%	+$1.9M	0.12%	151
2018 Q3	$3.29M	Buy	+476,000	New	+$3.18M	0.06%	243
2015 Q4	–	Sell	-393,695	Closed	-$5.03M	–	648
2015 Q3	$5.03M	Buy	393,695 +92,850	+31%	+$1.15M	0.15%	91
2015 Q2	$3.33M	Buy	300,845 +98,500	+49%	+$1.09M	0.1%	142
2015 Q1	$2.31M	Sell	202,345 -102,000	-34%	-$1.08M	0.07%	175
2014 Q4	$3.07M	Sell	304,345 -8,000	-3%	-$84.2K	0.11%	106
2014 Q3	$3.28M	Buy	312,345 +44,000	+16%	+$414K	0.12%	113
2014 Q2	$2.31M	Buy	268,345 +58,500	+28%	+$492K	0.09%	158
2014 Q1	$1.84M	Sell	209,845 -10,500	-5%	-$91.3K	0.07%	173
2013 Q4	$1.81M	Buy	220,345 +12,500	+6%	+$98.9K	0.08%	168
2013 Q3	$1.57M	Sell	207,845 -118,500	-36%	-$862K	0.07%	184
2013 Q2	$2.47M	Buy	+326,345	New	+$2.38M	0.11%	162

Other funds holding RDY

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

AIM

Aikya Investment Management London, United Kingdom $345M AUM 10.59% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

ClariVest Asset Management's RDY Position: Q2 2024 in Review

ClariVest Asset Management sold out of Dr. Reddy's Laboratories (RDY) in Q2 2024, closing a stake of 50,000 shares — an estimated $734K sold.

ClariVest Asset Management first reported a position in RDY in Q2 2013 and held it in 25 quarters. The position peaked at $5.63M in Q4 2018. 222 funds tracked by Wall St. Rank hold RDY as of Q2 2024.

ClariVest Asset Management reported no remaining Dr. Reddy's Laboratories position as of Q2 2024 after selling out during the quarter.
ClariVest Asset Management sold 50,000 Dr. Reddy's Laboratories shares in Q2 2024, an estimated $734K.
ClariVest Asset Management first reported a position in Dr. Reddy's Laboratories in Q2 2013 and held it in 25 quarters.
ClariVest Asset Management's Dr. Reddy's Laboratories position peaked at $5.63M in Q4 2018.
222 funds tracked by Wall St. Rank held Dr. Reddy's Laboratories as of Q2 2024.

Based on ClariVest Asset Management's 13F filing for Q2 2024, filed 7 Aug 2024.